Faeth Appoints Zymeworks R&D Head Adam Schayowitz to Board
Faeth appointed Adam Schayowitz, Zymeworks' head of research and development, to its board of directors.
Related stories
Alphabet Shares Trigger Death Cross After Post-Earnings Slide
Alphabet shares entered bearish territory after a post-earnings skid. The report says shares rebounded after four of the past five death crosses over the last decade, with an avera
M impact | EQUITY | Oct 29, 2026, 07:10 PM UTC
CVC Acquires Stake in Recordati
CVC acquired shares in Recordati on October 29, 2026.
M impact | EQUITY | Oct 29, 2026, 07:09 PM UTC
Perella Weinberg Partners Reports Quarterly Results
Perella Weinberg Partners reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 07:09 PM UTC
Polymarket Pauses Trading After $2.65 Million Exploit
Polymarket said it placed its exchange in cancel-only mode and paused relayer actions while investigating a compromise of a third-party provider. More than $2.6 million was lost wi
M impact | EQUITY | Oct 29, 2026, 07:01 PM UTC
A. O. Smith Reports Third-Quarter 2026 Revenue of $940.5 Million
Revenue fell 0.2% year over year to $940.5 million. Net income declined 4.3% to $126.3 million, while diluted EPS was $0.93 versus $0.94 a year earlier.
M impact | EQUITY | Oct 29, 2026, 07:01 PM UTC
Carrier Reports $2.59 Billion Third-Quarter Loss on $3.1 Billion Impairment
Carrier Global reported third-quarter 2026 revenue of $6.26 billion, up 12.3% year over year, and diluted EPS loss of $3.16. A $3.1 billion goodwill impairment was tied to weaker E
M impact | EQUITY | Oct 29, 2026, 07:01 PM UTC